Pharsight Welcomes Newest Japanese PKS, AutoPilo...( Global Deployment of Pharsight's ...)

Global Deployment of Pharsight's Automated PK/PD Data Management and

Reporting Solution

MOUNTAIN VIEW, Calif., Feb. 26 /PRNewswire-FirstCall/ -- Pharsight Corporation (Nasdaq: PHST), a leading provider of software and strategic services for optimizing clinical drug development, today announced that a top Japanese-based pharmaceutical company has purchased a clinical data management and reporting solution including Pharsight(R) Knowledgebase Server(TM) (PKS(TM)), WinNonlin(R) AutoPilot(TM), and PKS Reporter(TM). This sale marks the first sale of an enterprise solution through Pharsight's Japanese distributor CTC Laboratory Systems and the fourth new customer for WinNonlin AutoPilot since the product's release in June of last year. This new agreement brings Pharsight's total number of PKS customers to 22 and is the fourth sale to a Japanese Top 50 pharmaceutical firm.

By integrating PKS, WinNonlin AutoPilot, and PKS Reporter into one PK data management and reporting solution, customers benefit from the power of standardized and regulatory-compliant data handling and the efficiency of automation of common or repetitive tasks during clinical pharmacokinetic (PK) analysis. By using WinNonlin AutoPilot to create report-ready tables and graphs and PKS Reporter to finalize reports and to manage report updates, companies can vastly increase their productivity while improving the quality and consistency of analyses and reports.

"This purchase illustrates the success of our Japanese partners from CTC. It also demonstrates the need for global drug development organizations to achieve higher productivity and regulatory-compliant PK workflows that are enabled by our innovative tools," said Shawn O'Con
'/>"/>